Index D

D and C (dilatation and curettage): Sec. 3, Ch. 58

D-carnitine: Sec. 2, Ch. 7

D-dimer

in deep vein thrombosis: Sec. 3, Ch. 44

Dairy intolerance: Sec. 1, Ch. 2

Dalteparin: Sec. 3, Ch. 45

Dancing

Dandruff: Sec. 3, Ch. 35

Darbepoietin

in anemia of chronic disease: Sec. 3, Ch. 49

in chronic lymphocytic leukemia: Sec. 3, Ch. 51

in multiple myeloma: Sec. 3, Ch. 51

Dating: Sec. 4, Ch. 63

Dawn phenomenon: Sec. 3, Ch. 34

Day care centers: Sec. 2, Ch. 15

Day hospital: Sec. 2, Ch. 9

Daytime sleepiness: Sec. 3, Ch. 31; Sec. 3, Ch. 31

Deafness: (see Hearing, loss of)

Death

causes of: Sec. 1, Ch. 3; Sec. 2, Ch. 16

impending signs of: Sec. 2 Ch. 16 [sidebar]

information resources on: 884-885

of loved one: Sec. 4, Ch. 61

Death rattle: Sec. 2 Ch. 16 [sidebar]

Decibels: Sec. 3 Ch. 37 [sidebar]

Decision-making

advance directives and: Sec. 4, Ch. 65

capacity and: Sec. 4, Ch. 65

competence and: Sec. 4, Ch. 65

about driving: Sec. 4, Ch. 62

about health care: Sec. 4, Ch. 65

surrogate: Sec. 4, Ch. 65

Decongestants

urinary incontinence with: Sec. 3, Ch. 57

in viral rhinitis: Sec. 3, Ch. 38

Decubitus ulcers: (see Pressure sores)

Deep brain stimulation

in dystonia: Sec. 3, Ch. 30

in Parkinson's disease: Sec. 3, Ch. 30

Deep vein thrombosis: Sec. 3, Ch. 44

in disseminated intravascular coagulation: Sec. 3, Ch. 49

Defibrillation: Sec. 3, Ch. 47

Dehydration: Sec. 3, Ch. 18; Sec. 3, Ch. 17

in diarrhea: Sec. 3, Ch. 55

dry mouth with: Sec. 3, Ch. 39

during hospitalization: Sec. 2, Ch. 11

high calcium level and: Sec. 3, Ch. 18

high sodium level and: Sec. 3, Ch. 18

hyperthermia and: Sec. 3 Ch. 19 [detail]

orthostatic hypotension with: Sec. 3, Ch. 20

Dehydroepiandrosterone (DHEA)

supplemental: Sec. 2, Ch. 7

Delayed sleep phase syndrome: Sec. 3, Ch. 31

Delirium tremens (DTs): Sec. 3, Ch. 26

Delirium: Sec. 3, Ch. 25; Sec. 3, Ch. 26

drug-related: Sec. 3, Ch. 26

with hospitalization: Sec. 2, Ch. 11

after surgery: Sec. 2, Ch. 12

at end of life: Sec. 2, Ch. 16

Dementia: Sec. 3, Ch. 27; Sec. 3, Ch. 25 (see also Alzheimer's disease)

acetyl-L carnitine in: Sec. 2, Ch. 7

anxiety with: Sec. 3 Ch. 32 [sidebar]

delirium with: Sec. 3, Ch. 26

dental care in: Sec. 3, Ch. 39

depression with: Sec. 3 Ch. 32 [sidebar]

driving and: Sec. 4, Ch. 62

end-of-life care in: Sec. 3, Ch. 27

exercise in: Sec. 3, Ch. 60

ginkgo biloba in: Sec. 2, Ch. 7

home care and: Sec. 2, Ch. 15; Sec. 2 Ch. 14 [sidebar]

information resources on: 882

intimacy and: Sec. 4, Ch. 63

Lewy body: Sec. 3, Ch. 27

paranoia with: Sec. 3, Ch. 32

rehabilitation and: Sec. 2, Ch. 13

sleep disorders with: Sec. 3, Ch. 27; Sec. 3, Ch. 27; Sec. 3, Ch. 31

treatment of: Sec. 3, Ch. 27

vascular: Sec. 3, Ch. 27

Demographics

of aging: Sec. 1, Ch. 3; Sec. 1, Ch. 3

Densitometry

Dental plaque: Sec. 3, Ch. 39; Sec. 3, Ch. 39

Dental problems: (see Tooth [teeth])

Dental restorations: Sec. 3, Ch. 39

Dentures: Sec. 3, Ch. 39

dry mouth and: Sec. 3, Ch. 39

Depression: Sec. 3, Ch. 32

cancer-related: Sec. 3, Ch. 50

after death of loved one: Sec. 4, Ch. 61

in dementia: Sec. 3, Ch. 27; Sec. 3 Ch. 32 [sidebar]

DHEA supplements in: Sec. 2, Ch. 7

dizziness in: Sec. 3, Ch. 20

drugs for: (see Antidepressants)

forgetfulness and: Sec. 3, Ch. 32; Sec. 3 Ch. 27 [sidebar]

after heart attack: Sec. 3, Ch. 45; Sec. 3, Ch. 45

information resources on: 885

major: Sec. 3, Ch. 32

manic: Sec. 3, Ch. 32; Sec. 3, Ch. 32; Sec. 3, Ch. 32

melatonin and: Sec. 2, Ch. 7

in Parkinson's disease: Sec. 3, Ch. 30

psychotic: Sec. 3, Ch. 32

rehabilitation and: Sec. 2, Ch. 13

St. John's wort in: Sec. 2, Ch. 7

after stroke: Sec. 3, Ch. 28

treatment of: Sec. 3, Ch. 32

undernutrition and: Sec. 3 Ch. 17 [detail]; Sec. 3, Ch. 17

Depth perception: Sec. 1, Ch. 2

Dermatitis

seborrheic: Sec. 3, Ch. 35

     of vulva: Sec. 3, Ch. 58

Dermatologist: Sec. 2, Ch. 9

Dermatome: Sec. 3, Ch. 35

Dermis: Sec. 3 Ch. 35 [detail]; Sec. 3, Ch. 35

Desipramine

in depression: Sec. 3, Ch. 32

urinary incontinence with: Sec. 3, Ch. 57

Details

Detrusor muscle: Sec. 3, Ch. 57

Devices: (see Assistive devices)

DEXA (dual-energy x-ray absorptiometry) scan: Sec. 3, Ch. 22

Dexamethasone: Sec. 3, Ch. 51

Dextroamphetamine: Sec. 3, Ch. 32

DHEA (dehydroepiandrosterone)

supplemental: Sec. 2, Ch. 7

Diabetes mellitus: Sec. 3, Ch. 34

blood sugar monitoring in: Sec. 3, Ch. 34

complications of: Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3 Ch. 34 [sidebar]

coronary artery disease and: Sec. 3, Ch. 45; Sec. 3, Ch. 45

dizziness in: Sec. 3, Ch. 20; Sec. 3, Ch. 20; Sec. 3, Ch. 20; Sec. 3, Ch. 20

driving and: Sec. 4, Ch. 62

erectile dysfunction and: Sec. 3 Ch. 59 [detail]

exercise in: Sec. 3, Ch. 60

eye problems (retinopathy) in: Sec. 3, Ch. 36

high blood sugar levels (hyperglycemia) in: Sec. 3, Ch. 34

information resources on: 885

low blood sugar (hypoglycemia) in: Sec. 3, Ch. 34; Sec. 3, Ch. 60; Sec. 4, Ch. 62

nerve problems (neuropathy) in: Sec. 3, Ch. 29

orthostatic hypotension in: Sec. 3, Ch. 20

prevention of: Sec. 3, Ch. 34

screening for: Sec. 3, Ch. 34

treatment of: Sec. 3, Ch. 34

undernutrition and: Sec. 3 Ch. 17 [detail]

Diagnostic tests: (see Test[s])

Diaphragm: Sec. 3, Ch. 54

aging of: Sec. 1, Ch. 2

hernia of: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54

spasms of (hiccups): Sec. 3 Ch. 30 [sidebar]

Diarrhea: Sec. 3, Ch. 55

berberine and: Sec. 2, Ch. 7

with dairy products: Sec. 1, Ch. 2

in terminal illness: Sec. 2, Ch. 16

Diastolic blood pressure: Sec. 3, Ch. 43

Diathermy: Sec. 2, Ch. 13

for pain: Sec. 3, Ch. 24

Diazepam: Sec. 2, Ch. 6; Sec. 2, Ch. 6

urinary incontinence with: Sec. 3, Ch. 57

Diclofenac: Sec. 3, Ch. 41

Dicyclomine: Sec. 2, Ch. 6

in urinary tract infection: Sec. 3, Ch. 56

Diet: (see also Food; Nutrition)

acid reflux and: Sec. 3, Ch. 54

in atherosclerosis: Sec. 3, Ch. 44; Sec. 3, Ch. 44

cholesterol level and: Sec. 3, Ch. 44

in constipation: Sec. 3, Ch. 55; Sec. 3, Ch. 55

in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45

in diabetes: Sec. 3, Ch. 34; Sec. 3, Ch. 34

in gout: Sec. 3, Ch. 41; Sec. 3, Ch. 41

healthy: Sec. 2, Ch. 4; Sec. 3, Ch. 17

in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46

hospital: Sec. 2, Ch. 11

information resources on: 888

low-calorie: Sec. 1 Ch. 1 [sidebar]

low-fat: Sec. 2, Ch. 5; Sec. 1 Ch. 1 [sidebar]

low-protein: Sec. 2, Ch. 5

low-salt: Sec. 2, Ch. 5

Mediterranean: Sec. 1 Ch. 1 [sidebar]

in Parkinson's disease: Sec. 3, Ch. 30

in pressure sore prevention: Sec. 3, Ch. 35

in rheumatoid arthritis: Sec. 3, Ch. 41

in stroke prevention: Sec. 3, Ch. 28

tooth loss and: Sec. 3, Ch. 39

in vulvar pain prevention: Sec. 3, Ch. 58

Dietary supplements: Sec. 2, Ch. 7

drug interactions with: Sec. 2, Ch. 6; Sec. 2, Ch. 7; Sec. 2, Ch. 7

for nutritional disorders: Sec. 3, Ch. 17

safety of: Sec. 2, Ch. 7

Dietitian: Sec. 2, Ch. 9

Digestive system

aging of: Sec. 1, Ch. 2

endoscopy of: Sec. 2, Ch. 10; Sec. 2, Ch. 10

infection of: Sec. 3, Ch. 55; Sec. 3, Ch. 55

at end of life: Sec. 2, Ch. 16

problems of:

     information resources on: 885

Digital rectal examination

in benign prostatic hyperplasia: Sec. 3, Ch. 59

Digoxin: Sec. 2, Ch. 6

in abnormal heart rhythms: Sec. 3, Ch. 47

in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46

in heart valve disorders: Sec. 3, Ch. 48

undernutrition and: Sec. 3 Ch. 17 [detail]

Dilatation and curettage (D and C): Sec. 3, Ch. 58

Diltiazem

in abnormal heart rhythms: Sec. 3, Ch. 47

in coronary artery disease: Sec. 3, Ch. 45

in high blood pressure: Sec. 3, Ch. 43

urinary incontinence with: Sec. 3, Ch. 57

Dip stick (urine) tests: Sec. 3, Ch. 56

Diphenhydramine: Sec. 2, Ch. 6

in dystonia: Sec. 3, Ch. 30

in insomnia: Sec. 3, Ch. 31

side effects of: Sec. 2, Ch. 6

urinary incontinence with: Sec. 3, Ch. 57

Diphenoxylate: Sec. 3, Ch. 55

Diphtheria vaccine

Diplopia (double vision): Sec. 3, Ch. 42

Dipyridamole: Sec. 3, Ch. 49; Sec. 3 Ch. 49 [sidebar]

Disability

demographics of: Sec. 1, Ch. 3

exercise and: Sec. 3, Ch. 60

information resources on: 882, 885-886

Discharge

from hospital: Sec. 2, Ch. 11

Disease-modifying anti-rheumatic drugs: Sec. 3, Ch. 41; Sec. 3, Ch. 41

Disks

degenerative disease of: Sec. 3, Ch. 20

Disopyramide: Sec. 2, Ch. 6; Sec. 3, Ch. 47

Disorientation

in delirium: Sec. 3, Ch. 26

in dementia: Sec. 3, Ch. 27; Sec. 3, Ch. 27

in stroke: Sec. 3, Ch. 28

Disseminated intravascular coagulation: Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3, Ch. 49

Distance perception: Sec. 1, Ch. 2

Diuretics

dehydration with: Sec. 3, Ch. 18

dizziness with: Sec. 3, Ch. 20; Sec. 3, Ch. 20

fainting with: Sec. 3, Ch. 20; Sec. 3, Ch. 20

in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46

in heart valve disorders: Sec. 3, Ch. 48

in high blood pressure: Sec. 3, Ch. 43

high sodium levels with: Sec. 3, Ch. 18

low potassium levels with: Sec. 3, Ch. 18

in overhydration: Sec. 3, Ch. 18

undernutrition and: Sec. 3 Ch. 17 [detail]

in urge incontinence: Sec. 3, Ch. 57

urinary incontinence with: Sec. 3, Ch. 57

water consumption with: Sec. 2, Ch. 5

Diverticula

esophageal: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54

Dizziness: Sec. 3, Ch. 20

in abnormal heart rhythms: Sec. 3, Ch. 47

in stroke: Sec. 3, Ch. 28

tilt table therapy for: Sec. 2, Ch. 13

DNR: Sec. 4, Ch. 65

Do-not-resuscitate orders: Sec. 4, Ch. 65

Dobutamine: Sec. 3, Ch. 46

Doctor: Sec. 2, Ch. 4 (see also Primary care doctor)

communicating with: Sec. 2, Ch. 8

in nursing home: Sec. 2, Ch. 14

office of: Sec. 2, Ch. 9

types of: Sec. 2, Ch. 9; Sec. 2 Ch. 09 [sidebar]

Docusate: Sec. 3, Ch. 55; Sec. 3, Ch. 55

Dofetilide: Sec. 3, Ch. 47

Donepezil: Sec. 3, Ch. 27

Dopamine agonists

in Parkinson's disease: Sec. 3, Ch. 30; Sec. 3, Ch. 30

Dopamine

in heart failure: Sec. 3, Ch. 46

in Parkinson's disease: Sec. 3, Ch. 30

Doppler ultrasound: Sec. 2, Ch. 10

in deep vein thrombosis: Sec. 3, Ch. 44

in peripheral arterial disease: Sec. 3, Ch. 44

in stroke: Sec. 3, Ch. 28

Double voiding: Sec. 3, Ch. 57

Double vision: Sec. 3, Ch. 36; Sec. 3, Ch. 42

Dowager's hump: Sec. 3, Ch. 22; Sec. 3, Ch. 23

Doxazosin

in benign prostatic hyperplasia: Sec. 3, Ch. 59

in high blood pressure: Sec. 3, Ch. 43

in prostatitis: Sec. 3, Ch. 59

urinary incontinence with: Sec. 3, Ch. 57

Doxepin: Sec. 2, Ch. 6

in depression: Sec. 3, Ch. 32

Driver's license: Sec. 4, Ch. 62

Driving: Sec. 4, Ch. 62

cessation of: Sec. 4, Ch. 62

dementia and: Sec. 3, Ch. 27; Sec. 3, Ch. 27

information resources on: 886

Dronabinol: Sec. 3, Ch. 50

Drowsiness

Drugs: Sec. 2, Ch. 6

acid reflux with: Sec. 3, Ch. 54

alcohol interactions with: Sec. 3 Ch. 32 [sidebar]

anesthetic: Sec. 2, Ch. 12

anticholinergic effects of: Sec. 2, Ch. 6; Sec. 2, Ch. 6; Sec. 2, Ch. 12

anxiety symptoms with: Sec. 3, Ch. 32

aplastic anemia with: Sec. 3 Ch. 49 [sidebar]

for appetite stimulation: Sec. 3, Ch. 17

abnormal heart rhythms with: Sec. 3, Ch. 47

benefits of: Sec. 2, Ch. 6

benign prostatic hyperplasia with: Sec. 3, Ch. 59

body processing of: Sec. 2, Ch. 6; Sec. 2, Ch. 6

delirium with: Sec. 3 Ch. 26 [detail]; Sec. 3, Ch. 26

dementia and: Sec. 3, Ch. 27

diarrhea with: Sec. 3, Ch. 55

dietary supplement interactions with: Sec. 2, Ch. 6; Sec. 2, Ch. 7; Sec. 2, Ch. 7

dizziness with: Sec. 3, Ch. 20; Sec. 3, Ch. 20; Sec. 3, Ch. 20

dry mouth with: Sec. 3, Ch. 39

erectile dysfunction with: Sec. 3 Ch. 59 [detail]

esophageal damage with: Sec. 3, Ch. 54

fainting with: Sec. 3, Ch. 20; Sec. 3, Ch. 20

falls and: Sec. 3 Ch. 21 [detail]

gum growth with: Sec. 3, Ch. 39

hearing loss with: Sec. 3, Ch. 37

high blood pressure with: Sec. 3, Ch. 43

high potassium levels with: Sec. 3, Ch. 18

high sodium levels with: Sec. 3, Ch. 18

hyperthyroidism with: Sec. 3, Ch. 33

hypothyroidism with: Sec. 3, Ch. 33; Sec. 3, Ch. 33

information on: Sec. 2, Ch. 6; Sec. 2, Ch. 8

interactions of: Sec. 2, Ch. 6

label for: Sec. 2, Ch. 6

low potassium levels with: Sec. 3, Ch. 18

Medicare payment for: Sec. 4 Ch. 66 [sidebar]

nonprescription (over-the-counter): Sec. 2, Ch. 6

orthostatic hypotension with: Sec. 3, Ch. 20

overhydration with: Sec. 3, Ch. 18

pharmacist for: Sec. 2, Ch. 6; Sec. 2, Ch. 9; Sec. 2, Ch. 9

psychosis with: Sec. 3, Ch. 32

reminder systems for: Sec. 2, Ch. 6

rhinitis with: Sec. 3, Ch. 38

risks of: Sec. 2, Ch. 6

safe use of: Sec. 2, Ch. 6

schedule for: Sec. 2, Ch. 6; Sec. 2, Ch. 6; Sec. 2, Ch. 6

sensitivity to: Sec. 2, Ch. 6

side effects of: Sec. 2, Ch. 6; Sec. 2, Ch. 11

swallowing difficulty with: Sec. 3, Ch. 54

thyroid hormone interactions with: Sec. 3, Ch. 33

undernutrition and: Sec. 3 Ch. 17 [detail]

urinary incontinence with: Sec. 3, Ch. 57

vitamin D processing and: Sec. 3, Ch. 18

weight gain with: Sec. 3, Ch. 17

for weight reduction: Sec. 3, Ch. 17

Dry eye: Sec. 1, Ch. 2; Sec. 3, Ch. 36

Dry gangrene: Sec. 3, Ch. 44

Dry mouth: Sec. 1, Ch. 2; Sec. 3, Ch. 39

after radiation therapy: Sec. 3, Ch. 51

Dry skin: Sec. 3, Ch. 35

DTs (delirium tremens): Sec. 3, Ch. 26

Dual-energy x-ray absorptiometry (DEXA) scan: Sec. 3, Ch. 22

Dupuytren's contracture: Sec. 3, Ch. 34

Durable power of attorney for health care: Sec. 2, Ch. 12; Sec. 2, Ch. 16; Sec. 4, Ch. 65

Dutasteride: Sec. 3, Ch. 59

for cardiac angiography: Sec. 2, Ch. 10

for CT scan: Sec. 2, Ch. 10

for MRI: Sec. 2, Ch. 10

Dying: (see End-of-life care)

Dysarthria

rehabilitation for: Sec. 2, Ch. 13

in stroke: Sec. 3, Ch. 28

Dysequilibrium: Sec. 3, Ch. 20

Dyskinesia

tardive: Sec. 3, Ch. 30; Sec. 3, Ch. 32

Dysphagia: Sec. 3, Ch. 54

Dysphonia

spasmodic: Sec. 3, Ch. 30

Dysthymic disorder: Sec. 3, Ch. 32

Dystonia: Sec. 3, Ch. 30

Dysuria: Sec. 3, Ch. 56